Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Total Non-Current Liabilities (2019 - 2025)

Historic Total Non-Current Liabilities for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $149.7 million.

  • Harmony Biosciences Holdings' Total Non-Current Liabilities fell 1197.28% to $149.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $149.7 million, marking a year-over-year decrease of 1197.28%. This contributed to the annual value of $165.0 million for FY2024, which is 869.63% down from last year.
  • Harmony Biosciences Holdings' Total Non-Current Liabilities amounted to $149.7 million in Q3 2025, which was down 1197.28% from $154.8 million recorded in Q2 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' Total Non-Current Liabilities peaked at $196.5 million during Q2 2021, and registered a low of $149.7 million during Q3 2025.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $184.0 million (2023), whereas its average is $180.6 million.
  • Per our database at Business Quant, Harmony Biosciences Holdings' Total Non-Current Liabilities soared by 40.32% in 2022 and then plummeted by 1197.28% in 2025.
  • Quarter analysis of 5 years shows Harmony Biosciences Holdings' Total Non-Current Liabilities stood at $193.2 million in 2021, then dropped by 0.52% to $192.1 million in 2022, then dropped by 5.97% to $180.7 million in 2023, then decreased by 8.7% to $165.0 million in 2024, then fell by 9.26% to $149.7 million in 2025.
  • Its Total Non-Current Liabilities stands at $149.7 million for Q3 2025, versus $154.8 million for Q2 2025 and $159.9 million for Q1 2025.